Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer
International Journal of Molecular Sciences · 06.05.2025 · 26 (9) · 4404
DOI: 10.3390/ijms26094404 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.05.2025. Verfasst von Anna Niechcial und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Colorectal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PiLeJe SA, France.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide with limited treatment options for advanced disease stages. Growing evidence implicates the gut microbiota in CRC pathogenesis, prompting interest in probiotics as a potential therapeutic strategy. In this study, we evaluated the effects of two probiotic compositions, CI (a mix of lactobacilli and bifidobacteria) and CII (bifidobacteria alone), in two murine CRC models: the orthotopic MC-38 cecum injection model and the inflammation-driven azoxymethane/dextran sodium sulfate (AOM/DSS) model. CI showed significant anti-tumor effects in the orthotopic model, reducing tumor weight and volume, which was, however, not associated with robust immune activation, suggesting microbiota-driven mechanisms. In contrast, CII was more effective in the AOM/DSS model, reducing colonic inflammation and completely preventing tumor development. Our study demonstrates that probiotics might have great therapeutic potential via modulation of the gut microbiota, and they can exert anti-tumor effects in murine models of CRC with distinct compositions showing differential efficacy depending on the model. CI stabilized the gut microbiome and inhibited pro-tumorigenic taxa in the MC-38 cecum injection model, while CII exhibited anti-inflammatory properties in the AOM/DSS model, highlighting the potential of probiotics as context-specific interventions for CRC. These findings contribute to the growing body of evidence supporting microbiota-targeted strategies in oncology and their relevance for therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
- PiLeJe Laboratoire, 49270 Paris, France.
ORCID-Profile: Marlene Schwarzfischer, Paulina Wawrzyniak, Marcin Wawrzyniak, Emilie Gueguen, Maria R Walker, Yasser Morsy, Marijn Wilmink, Marianne R Spalinger, Anne Leblanc
Förderung
- PiLeJe SA, France
Zitieren
APA
Niechcial, A., Schwarzfischer, M., Wawrzyniak, P., Determann, M., Pöhlmann, D., Wawrzyniak, M., Gueguen, E., Walker, M. R., Morsy, Y., Atrott, K., Wilmink, M., Linzmeier, L., Spalinger, M. R., Holowacz, S., Leblanc, A., & Scharl, M. (2025). Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer. International Journal of Molecular Sciences, 26(9), 4404. https://doi.org/10.3390/ijms26094404
Vancouver
Niechcial A, Schwarzfischer M, Wawrzyniak P, Determann M, Pöhlmann D, Wawrzyniak M, et al. Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer. International Journal of Molecular Sciences. 2025;26(9):4404. doi:10.3390/ijms26094404
BibTeX
@article{Niechcial2025,
author = {Niechcial, Anna and Schwarzfischer, Marlene and Wawrzyniak, Paulina and Determann, Madita and Pöhlmann, Doris and Wawrzyniak, Marcin and Gueguen, Emilie and Walker, Maria R and Morsy, Yasser and Atrott, Kirstin and Wilmink, Marijn and Linzmeier, Luise and Spalinger, Marianne R and Holowacz, Sophie and Leblanc, Anne and Scharl, Michael},
title = {Probiotic Administration Modulates Gut Microbiota and Suppresses Tumor Growth in Murine Models of Colorectal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4404},
doi = {10.3390/ijms26094404}
}
EUVIMED